Calcium Channel Blocker Toxicity: A Practical Approach

References

• Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004. doi:10.1097/hjh.0000000000002453
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–132. doi:10.1016/j.jacc.2019.01.011
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Beuhler MC, et al. 2020 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 38th annual report. Clin Toxicol. 2021;59(12):1282–1501. doi:10.1080/15563650.2021.1989785
   PubMed Web of Science ®Google Scholar
• Christensen MB, Petersen KM, Bøgevig S, et al. Outcomes following calcium channel blocker exposures reported to a poison information center. BMC Pharmacol Toxicol. 2018;19(1):78. doi:10.1186/s40360-018-0271-9
   PubMed Web of Science ®Google Scholar
• Chakraborty RK, Hamilton RJ. Calcium channel blocker toxicity. In: StatPearls. StatPearls Publishing; 2018.
   Google Scholar
• Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol. 1997;145(2):357–362. doi:10.1006/taap.1997.8195
   PubMed Web of Science ®Google Scholar
• Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother. 2005;39(5):923–930. doi:10.1345/aph.1E436
   PubMed Web of Science ®Google Scholar
• Ramoska EA, Spiller HA, Myers A. Calcium channel blocker toxicity. Ann Emerg Med. 1990;19(6):649–653. doi:10.1016/s0196-0644(05)82469-2
   PubMed Web of Science ®Google Scholar
• Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016;81(3):453–461. doi:10.1111/bcp.12763
   PubMed Web of Science ®Google Scholar
• DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23(4):223–238. doi:10.2165/00139709-200423040-00003
   PubMedGoogle Scholar
• Proano L, Chiang WK, Wang RY. Calcium channel blocker overdose. Am J Emerg Med. 1995;13(4):444–450. doi:10.1016/0735-6757(95)90137-x
   PubMed Web of Science ®Google Scholar
• Schoffstall JM, Spivey WH, Gambone LM, Shaw RP, Sit SP. Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med. 1991;20(10):1104–1108. doi:10.1016/s0196-0644(05)81384-8
   PubMed Web of Science ®Google Scholar
• Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest. 2001;119(4):1280–1282. doi:10.1378/chest.119.4.1280
   PubMed Web of Science ®Google Scholar
• McAllister RG, Hamann SR, Blouin RA. Pharmacokinetics of calcium-entry blockers. Am J Cardiol. 1985;55(3):30b–40b. doi:10.1016/0002-9149(85)90611-3
   PubMed Web of Science ®Google Scholar
• Yoshida M, Matsumoto T, Suzuki T, Kitamura S, Mayama T. Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker. Pharmacoepidemiol Drug Saf. 2008;17(1):70–75. doi:10.1002/pds.1480
   PubMed Web of Science ®Google Scholar
• Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. Cmaj. 2011;183(3):303–307. doi:10.1503/cmaj.100702
   PubMed Web of Science ®Google Scholar
• Rosenthal T, Ezra D. Calcium antagonists. Drug interactions of clinical significance. Drug Saf. 1995;13(3):157–187. doi:10.2165/00002018-199513030-00003
   PubMed Web of Science ®Google Scholar
• Drug interactions with the calcium-channel blockers. Available from: 10.10520/EJC63124. Accessed August 3, 2022.
   Google Scholar
• Opie LH. Calcium channel antagonists: part VI: clinical pharmacokinetics of first and second-generation agents. Cardiovasc Drugs Ther. 1989;3(4):482–497. doi:10.1007/bf01865507
   PubMed Web of Science ®Google Scholar
• Spiller HA, Meyers A, Ziemba T, Riley M. Delayed onset of cardiac arrhythmias from sustained-release verapamil. Ann Emerg Med. 1991;20(2):201–203. doi:10.1016/s0196-0644(05)81224-7
   PubMed Web of Science ®Google Scholar
• Tom PA, Morrow CT, Kelen GD. Delayed hypotension after overdose of sustained release verapamil. J Emerg Med. 1994;12(5):621–625. doi:10.1016/0736-4679(94)90414-6
   PubMedGoogle Scholar
• Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med. 1993;22(2):196–200. doi:10.1016/s0196-0644(05)80202-1
   PubMed Web of Science ®Google Scholar
• Calan SR (verapamil hydrochloride) [package insert]. New York, NY 10017: Pfizer; 2022.
   Google Scholar
• CARDIZEM CD (diltiazem hydrochloride) [package insert]. Bridgewater, NJ 08807: Bausch Health Companies Inc; 2020.
   Google Scholar
• NORVASC (amlodipine besylate) [package insert]. New York, NY 10017: Pfizer; 2017.
   Google Scholar
• Nicardipine hydrochloride [package insert]. Laurelton, NY 11413: Epic Pharma, LLC; 2017.
   Google Scholar
• PLENDIL (felodipine) [package insert]. Wilmington, DE 19850: AstraZeneca LP; 2012.
   Google Scholar
• Bartlett JW, Walker PL. Management of calcium channel blocker toxicity in the pediatric patient. J Pediatr Pharmacol Ther. 2019;24(5):378–389. doi:10.5863/1551-6776-24.5.378
   PubMedGoogle Scholar
• Anderson AC. Calcium-channel blocker overdose. Clin Ped Emerg Med. 2005;6:109–115. doi:10.1016/j.cpem.2005.04.007
   Google Scholar
• Deters M, Bergmann I, Enden G, et al. Calcium channel antagonist exposures reported to the poisons information center Erfurt. Eur J Intern Med. 2011;22(6):616–620. doi:10.1016/j.ejim.2011.05.002
   PubMed Web of Science ®Google Scholar
• Bartlett D. β-blocker and calcium channel blocker poisoning: high-dose insulin/glucose therapy. Crit Care Nurse. 2016;36(2):45–50. doi:10.4037/ccn2016370
   PubMed Web of Science ®Google Scholar
• St-Onge M, Anseeuw K, Cantrell FL, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med. 2017;45(3):e306–e315. doi:10.1097/ccm.0000000000002087
   PubMedGoogle Scholar
• Lindeman E, Ålebring J, Johansson A, Ahlner J, Kugelberg FC, Nordmark Grass J. The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study. Clin Toxicol. 2020;58(11):1042–1049. doi:10.1080/15563650.2020.1725034
   PubMed Web of Science ®Google Scholar
• Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071–2075. doi:10.1097/01.ccm.0000278916.04569.23
   PubMed Web of Science ®Google Scholar
• Kerns W. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25(2):309–31; abstract viii. doi:10.1016/j.emc.2007.02.001
   PubMed Web of Science ®Google Scholar
• van Hoving DJ, Hunter LD, Gerber REJ, Lategan HJ, Marks CJ. The burden of intentional self-poisoning on a district-level public Hospital in Cape Town, South Africa. Afr J Emerg Med. 2018;8(3):79–83. doi:10.1016/j.afjem.2018.03.002
   PubMed Web of Science ®Google Scholar
• Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49(4):277–283. doi:10.3109/15563650.2011.582471
   Web of Science ®Google Scholar
• Benson BE, Spyker DA, Troutman WG, Watson WA, Bakhireva LN. Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data. J Emerg Med. 2010;39(2):186–193. doi:10.1016/j.jemermed.2009.02.016
   PubMed Web of Science ®Google Scholar
• April MD, Arana A, Schauer SG, et al. Ketamine versus etomidate and peri-intubation hypotension: a National Emergency Airway Registry Study. Acad Emerg Med. 2020;27(11):1106–1115. doi:10.1111/acem.14063
   PubMed Web of Science ®Google Scholar
• Lodhi FAK, Shogren SL, Vedre JG, Haque N, Reriani M, Ali R. Calcium channel blocker toxicity causing acute respiratory distress syndrome: a commonly used drug triggering a life-threatening condition. Wmj. 2020;119(1):66–68.
   PubMedGoogle Scholar
• Bryant SM, Naples J. Morbidity associated with whole bowel irrigation. Pediatr Emerg Care. 2007;23(11):846. doi:10.1097/PEC.0b013e31815a0679
   PubMed Web of Science ®Google Scholar
• Albertson TE, Owen KP, Sutter ME, Chan AL. Gastrointestinal decontamination in the acutely poisoned patient. Int J Emerg Med. 2011;4:65. doi:10.1186/1865-1380-4-65
   PubMedGoogle Scholar
• Thompson AM, Robins JB, Prescott LF. Changes in cardiorespiratory function during gastric lavage for drug overdose. Hum Toxicol. 1987;6(3):215–218. doi:10.1177/096032718700600307
   PubMedGoogle Scholar
• Cumpston KL, Aks SE, Sigg T, Pallasch E. Whole bowel irrigation and the hemodynamically unstable calcium channel blocker overdose: primum non nocere. J Emerg Med. 2010;38(2):171–174. doi:10.1016/j.jemermed.2007.11.100
   PubMed Web of Science ®Google Scholar
• Buckley N, Dawson AH, Howarth D, Whyte IM. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust. 1993;158(3):202–204. doi:10.5694/j.1326-5377.1993.tb121705.x
   PubMed Web of Science ®Google Scholar
• Laine K, Kivistö KT, Neuvonen PJ. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol. 1997;35(3):263–268. doi:10.3109/15563659709001210
   PubMed Web of Science ®Google Scholar
• Laine K, Kivistö KT, Laakso I, Neuvonen PJ. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol. 1997;43(1):29–33. doi:10.1111/j.1365-2125.1997.tb00029.x
   PubMed Web of Science ®Google Scholar
• Cole JB, Arens AM. Cardiotoxic medication poisoning. Emerg Med Clin North Am. 2022;40(2):395–416. doi:10.1016/j.emc.2022.01.014
   PubMed Web of Science ®Google Scholar
• Isbister GK. Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium. Emerg Med J. 2002;19(4):355–357. doi:10.1136/emj.19.4.355
   PubMed Web of Science ®Google Scholar
• St-Onge M, Dubé PA, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol. 2014;52(9):926–944. doi:10.3109/15563650.2014.965827
   PubMed Web of Science ®Google Scholar
• Sim MT, Stevenson FT. A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose. J Med Toxicol. 2008;4(1):25–29. doi:10.1007/bf03160947
   PubMedGoogle Scholar
• Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36(10):1817–1824. doi:10.1016/j.ajem.2018.02.004
   PubMed Web of Science ®Google Scholar
• Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013;51(4):201–207. doi:10.3109/15563650.2013.770152
   Web of Science ®Google Scholar
• Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010;48(8):806–812. doi:10.3109/15563650.2010.521753
   Web of Science ®Google Scholar
• Woodward C, Pourmand A, Mazer-Amirshahi M. High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity. Daru. 2014;22(1):36. doi:10.1186/2008-2231-22-36
   PubMed Web of Science ®Google Scholar
• Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care. 2002;18(1):36–37. doi:10.1097/00006565-200202000-00012
   PubMed Web of Science ®Google Scholar
• Levine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med. 2013;62(3):252–258. doi:10.1016/j.annemergmed.2013.03.018
   PubMed Web of Science ®Google Scholar
• Rothschild L, Bern S, Oswald S, Weinberg G. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med. 2010;18:51. doi:10.1186/1757-7241-18-51
   PubMed Web of Science ®Google Scholar
• Sepulveda EA, Pak A. Lipid emulsion therapy. In: StatPearls. StatPearls Publishing; 2022.
   Google Scholar
• Ok SH, Hong JM, Lee SH, Sohn JT. Lipid emulsion for treating local anesthetic systemic toxicity. Int J Med Sci. 2018;15(7):713–722. doi:10.7150/ijms.22643
   PubMed Web of Science ®Google Scholar
• American College of Medical Toxicology jmt@ acmt. net. ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7(1):81–82. doi:10.1007/s13181-010-0125-3
   PubMedGoogle Scholar
• Liang CW, Diamond SJ, Hagg DS. Lipid rescue of massive verapamil overdose: a case report. J Med Case Rep. 2011;5:399. doi:10.1186/1752-1947-5-399
   PubMedGoogle Scholar
• Ahmed S, Barnes S. Hemodynamic improvement using methylene blue after calcium channel blocker overdose. World J Emerg Med. 2019;10(1):55–58. doi:10.5847/wjem.j.1920-8642.2019.01.009
   PubMed Web of Science ®Google Scholar
• Lenasi H, Kohlstedt K, Fichtlscherer B, Mülsch A, Busse R, Fleming I. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovasc Res. 2003;59(4):844–853. doi:10.1016/s0008-6363(03)00505-4
   PubMed Web of Science ®Google Scholar
• Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010;26(4):517–520. doi:10.4103/0970-9185.74599
   PubMedGoogle Scholar
• Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol. 2013;9(3):242–249. doi:10.1007/s13181-013-0298-7
   PubMedGoogle Scholar
• Fadhlillah F, Patil S. Pharmacological and mechanical management of calcium channel blocker toxicity. BMJ Case Rep. 2018;2018. doi:10.1136/bcr-2018-225324
   PubMedGoogle Scholar
• Saha BK, Bonnier A, Chong W. Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning. Afr J Emerg Med. 2020;10(4):284–287. doi:10.1016/j.afjem.2020.06.014
   PubMed Web of Science ®Google Scholar
• Rutledge C, Brown B, Benner K, Prabhakaran P, Hayes L, Novel A. Use of methylene blue in the pediatric ICU. Pediatrics. 2015;136(4):e1030–e1034. doi:10.1542/peds.2014-3722
   PubMed Web of Science ®Google Scholar
• Shanmugam G. Vasoplegic syndrome–the role of methylene blue. Eur J Cardiothorac Surg. 2005;28(5):705–710. doi:10.1016/j.ejcts.2005.07.011
   PubMed Web of Science ®Google Scholar
• Wong A, Hoffman RS, Walsh SJ, et al. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol. 2021;59(5):361–375. doi:10.1080/15563650.2020.1870123
   PubMed Web of Science ®Google Scholar
• Haughey R, Vernick W, Gutsche J, Laudanski K. Use of veno-venous extracorporeal membrane oxygenation to treat severe combined calcium channel blocker and angiotensin converting enzyme inhibitor overdose. Perfusion. 2019;34(2):167–169. doi:10.1177/0267659118798181
   PubMed Web of Science ®Google Scholar
• Sutar A, Venkategowda PM, Murthy A, Chikkaswamy SB. Severe amlodipine toxicity: a case rescued with extracorporeal membrane oxygenation. Indian J Crit Care Med. 2020;24(5):365–366. doi:10.5005/jp-journals-10071-23423
   PubMed Web of Science ®Google Scholar